Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Puma Biotechnology, Inc. logo

Puma Biotechnology, Inc. (PBYI) Stock Ticker

NASDAQ: PBYI · Healthcare · Biotechnology
$9.77-0.51%
USD · as of 2026-09-28 · market cap $497.3M
Open PBYI in TickrDownload for iPhone

PBYI right now

Options expect by Oct 6±11.1%
Options expect by Oct 29±23.0%
Priced in for Nov 5 earnings±25.6%
IV rank (30-day)16% · cheap
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full PBYI picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on PBYI
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications. These include patients with early-stage HER2-overexpressed/amplified breast cancer, as well as adults suffering from advanced or metastatic HER2-positive breast cancer when used in combination with capecitabine. Furthermore, PB272 is being explored for solid tumors exhibiting HER2 mutations. The company holds a licensing agreement with Pfizer, Inc. for this drug and has established sub-licensing partnerships with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. Established in 2010, Puma Biotechnology maintains its headquarters in Los Angeles, California.

PBYI stock facts

Ticker symbolPBYI
ExchangeNASDAQ Global Select
SectorHealthcare
IndustryBiotechnology
Market cap$497.3M
CEOAlan H. Auerbach
Employees179
HeadquartersLos Angeles, CA, US
IPO date2012-04-24
Websitewww.pumabiotechnology.com

What you can see for PBYI on Tickr

Live PBYI price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the PBYI report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Puma Biotechnology, Inc.?

The ticker symbol for Puma Biotechnology, Inc. is PBYI, listed on the NASDAQ Global Select.

What is PBYI?

Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications. These include patients with early-stage HER2-overexpressed/amplified breast cancer, as well as adults suffering from advanced or metastatic…

HomeExploreMarketLists
All pages